https://www.avient.com/sites/default/files/2021-10/remafin-ep-white-masterbatches-for-pharma-application-bulletin_0.pdf
Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for: (1) exposure to human tissue or body fluids for 30 days or greater; (2) “plastic” (cosmetic or reconstructive) surgery use; (3) reproductive implants or any birth control device; or (4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life.
https://www.avient.com/sites/default/files/2022-03/AVNT Mar 2022 Presentation.pdf
We are Avient. 6 BETTER TOGETHER: POLYONE AND CLARIANT COLOR Key Financial Data 2021 Sales $4.8 billion 2021 EBITDA $581 million 87% of EBITDA from specialty applications 2021 PE RF O RM AN CE $80 $85 2020 2021 $0.52 $0.58 2020 2021 Q4 2021 PERFORMANCE (TOTAL COMPANY) 8 Sales Adjusted Operating Income $997 $1,202 2020 2021 + 21% Adjusted EPS + 6% + 12% (in millions) (in millions) $308 $429 2020PF 2021 $1.93 $3.05 2020PF 2021 FULL YEAR 2021 PERFORMANCE (TOTAL COMPANY) 9 Sales Adjusted Operating Income $3,783 $4,819 2020PF 2021 + 27% Adjusted EPS + 39% + 58% (in millions) (in millions) (1) Financial information is pro forma to include a full year of Clariant Color business (1) (1) (1) FULL YEAR 2021 SEGMENT PERFORMANCE 10 CAI $2,043 $2,402 Sales ($ in millions) SEM Distribution $226 $303 Operating Income + 18% + 34% $1,110 $1,631 Sales $70 $93 Operating Income + 47% + 33% (1) $709 $919 Sales $94 $132 Operating Income + 30% + 40% (1) Financial information is pro forma to include a full year of Clariant Color business (1) Full Year 2020 (Pro forma) $3,783 $308 Sustainable Solutions 147 19% 60 Healthcare 143 28% 30 Composites 58 43% 29 Growth in Asia / LATAM 107 21% 26 Other 543 30% 58 Sub-total $4,781 26% $511 Wage Inflation and Overtime (39) Other Supply Chain Costs (15) COVID Response Applications (22) (12) Synergies 44 FX, Incentives, Other Employee Costs 60 (60) Full Year 2021 $4,819 27% $429 FULL YEAR 2021 SALES AND OPERATING INCOME (TOTAL COMPANY) 11 Sales Growth Rate Adjusted Operating Income$ millions (1) Financial information is pro forma to include a full year of Clariant Color business (1) Adjusted EBITDA 12 Full Year 2020 (Pro forma) $ 457 Demand 135 $ millions CAI: Price / Mix 158 Inflation (120) SEM: Price / Mix 84 Inflation (65) Distribution: Price / Mix 318 Inflation (304) Net Price Benefit 71 Wage Inflation and Overtime (39) Other Supply Chain Costs (15) COVID Response Applications (12) Synergies 44 Incentives, FX, Other Employee Costs (60) Full Year 2021 $ 581 (1) Financial information is pro forma to include a full year of Clariant Color business (1) • Demand impact driven by growth in key focus areas: sustainable solutions, healthcare, composites and growth in Asia / LATAM • Price increases more than offset raw material and supply chain impacts FULL YEAR 2021 EBITDA BRIDGE SPECIALTY EBITDA MARGIN EXPANSION 13 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Color business 15.3% 15.2% 16.2% 17.0% 2018 2019 2020 2021 14.8% 15.2% 17.6% 17.8% 2018 2019 2020 2021 (1) SEM • Record margins in 2021 despite unprecedented supply chain challenges • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Color synergy realization • Investments in composites and outdoor high performance applications drove growth and mix improvements • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $54 million of synergies realized in 2021 • Acquisition completed on July 1, 2020 for $1.45 billion.
Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 30 Capex / Revenue 2022E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 3 3 4 3 3 5 5 5 7 7 7 A vi e nt A vi e nt ( E xc l.
APPENDIX Performance Additives 15% Pigments 13% TiO2 11% Dyestuffs 3%Polyethylene 12% Nylon 6% Polypropylene 5% Other Raw Materials 30% Styrenic Block Copolymer 5% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 35 • Significant raw material price inflation and tight inventory continued in Q4 2021 o For the full year, the average cost of hydrocarbon based materials was up 50% in 2021 o For the full year, the average cost of non- hydrocarbon based materials was up 12% in 2021 • Additionally, we continued to experience other supply chain challenges during Q4 related to raw material spot purchases, freight constraints and productivity loss as a result of these shortages Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2021 purchases, excludes Distribution business SEGMENT DATA U.S. & Canada 50% EMEA 25% Asia 16% Latin America 9% 2021 SEGMENT, END MARKET AND GEOGRAPHY 37 GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 19% Industrial 16% Building and Construction 10% Telecommunications 4% Energy 2% END MARKET REVENUE (1) Total company sales and adjusted EBITDA of $4,819M and $581M, respectively, include intercompany sales eliminations and corporate costs $2,402M $409M $919M $164M $1,631M $94M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $581M$4,819M (1) Transportation 11% Healthcare 15% Packaging 34% Consumer 21% Healthcare 8% Industrial 16% Building & Construction 10% Transportation 9% Energy 1% Telecommunications 1% C O L O R , A D D I T I V E S & I N K S 2021 REVENUE | $2 .4 BILL ION US & Canada 32% EMEA 40% Asia 21% Latin America 7% END MARKET REGION 38 All charts reflect 2021 financials S P E C I A LT Y E N G I N E E R E D M AT E R I A L S Consumer 27% Healthcare 10% Packaging 7% Telecommunications 16% Transportation 11% Industrial 11% Building & Construction 11% Energy 7% 2021 REVENUE | $919 MILLION END MARKET US & Canada 55% EMEA 25% Asia 20% REGION 39 All charts reflect 2021 financials DI S TR IBU T I ON Healthcare 26% Consumer 23% Packaging 5% Industrial 20% Transportation 16% Building and Construction 8% Energy 1% Telecommunications 1% US & Canada 80% Asia 3% Latin America 17% END MARKET REGION K E Y S U P P L I ER S 2021 REVENUE | $1 .6 B ILL ION 40 All charts reflect 2021 financials TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET Packaging 30% Consumer 26%Healthcare 13% Industrial 14% Building & Construction 5% Telecommunications 2% Energy 2% Asia (16% of sales) Transportation 8% Packaging 32% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 12% Telecommunications 5% Energy 4% EMEA (25% of sales) Transportation 12% 41 Consumer 25% Healthcare 19% Packaging 10% Industrial 17% Building & Construction 10% Telecommunications 4% Energy 2% US & Canada (50% of sales) Transportation 13% Packaging 38% Consumer 33% Healthcare 8% Industrial 10% Building & Construction 5% Telecommunications 1% LATAM (9% of sales) Transportation 5% All charts reflect 2021 financials
https://www.avient.com/sites/default/files/2021-12/avient-s.a-r.l.-excerpt-from-italian-companies-register.pdf
LUSSEMBURGO Domicilio digitale/PEC polyonesarl@legalmail.it Numero REA VA - 370258 Codice fiscale e n.iscr. al Registro Imprese 03669670121 Partita IVA 03669670121 Forma giuridica societa' costituita in base a leggi di altro stato Data iscrizione 07/09/2018 Data ultimo protocollo 30/11/2021 Preposto Della Sede Secondaria FUSI ALBERTO Rappresentante dell'Impresa ATTIVITA' Stato attività attiva Data inizio attività 31/10/2018 Attività prevalente commercio all'ingrosso di materiali coloranti per materie plastiche.
Classificazione ATECORI 2007 dell'attività prevalente (classificazione desunta dall’attività dichiarata) Codice: 46.73.4 - commercio all'ingrosso di carta da parati, colori e vernici Importanza: prevalente svolta dall'impresa Addetti (elaborazione da fonte INPS) Numero addetti dell'impresa rilevati nell'anno 2021 (Dati rilevati al 30/06/2021) Registro Imprese Archivio ufficiale della CCIAA Documento n .
Codice Fiscale 03669670121 Visura ordinaria societa' di capitale • di 5 10 I trimestre II trimestre Valore medio Dipendenti 9 9 9 Indipendenti 0 0 0 Totale 9 9 9 Distribuzione dipendenti Distribuzione per Contratto (Dati in percentuale rilevati al 30/06/2021) I trimestre II trimestre Tempo Indeterminato Distribuzione per Orario di lavoro (Dati in percentuale rilevati al 30/06/2021) I trimestre II trimestre Tempo Pieno Distribuzione per Qualifica (Dati in percentuale rilevati al 30/06/2021) I trimestre II trimestre Impiegato Quadro Dirigente Addetti nel comune di GALLARATE (VA) Unità locali: 1 I trimestre II trimestre Valore medio Dipendenti 7 7 7 Indipendenti 0 0 0 Totale 7 7 7 Addetti nel comune di 9638 POMMERLOCH Unità locali: 1 I trimestre II trimestre Valore medio Dipendenti 2 2 2 Indipendenti 0 0 0 Totale 2 2 2 Albi e Ruoli Registro Imprese Archivio ufficiale della CCIAA Documento n .
https://www.avient.com/sites/default/files/2025-03/380605_AVIENT_2024AR_full_250325.pdf
Year Ended December 31, 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 169.5 $ 1.84 $ 75.8 $ 0.83 Special items, after-tax 15.9 0.17 79.3 0.86 Amortization expense, after-tax 59.5 0.65 61.5 0.67 Adjusted net income / EPS $ 244.9 $ 2.66 $ 216.6 $ 2.36 (1) Per share amounts may not recalculate from figures presented herein due to rounding Year Ended December 31, Reconciliation to EBITDA and Adjusted EBITDA: 2024 2023 Net income from continuing operations – GAAP $ 170.7 $ 76.3 Income tax expense 54.1 11.0 Interest expense 105.6 115.3 Depreciation and amortization from continuing operations 179.7 188.8 EBITDA from continuing operations $ 510.1 $ 391.4 Special items, before tax 20.1 114.6 Interest expense included in special items (2.3) (2.3) Depreciation and amortization included in special items (1.5) (1.9) Adjusted EBITDA $ 526.4 $ 501.8 Adjusted EBITDA as a percent of sales 16.2 % 16.0 % Corporate Officers Ashish K.
https://www.avient.com/knowledge-base/article/polymer-services-frequency-asked-questions
Aug 03, 2023
https://www.avient.com/sites/default/files/2020-10/case-study-one-pager-trilliant-xr-xray-glasses.pdf
MEDICAL EQUIPMENT MANUFACTURER S U R G I C A L X - R A Y G L A S S E S • Replace lead while providing uniform shielding performance • Radiation shielding up to 140KeV • Improve glasses design • Compliance with Radiation Protection Regulation: Adult eye exposure must be below 20 mSv per calendar year • Conducted extensive testing to ensure comparable and uniform shielding performance • Improved geometric flexibility • Lowered shielding component costs 30-50% by eliminating machining and assembly steps (associated with lead) • Reduced weight of the glasses and enabled a more ergonomic design • Eliminated disposal concerns associated with lead Trilliant™ XR Lead Replacement Thermoplastics KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2020-07/case-study-one-pager-therma-tech-automotive-led-heat-sink_0.pdf
© 2019, All Right Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 TRANSPORTATION LIGHTING SUPPLIER H E A T S I N K F O R H I G H P O W E R L E D • A material to replace aluminum • High thermal conductivity - 20 W/mK • Electrically conductive • Increase production rate by 50%, as three secondary operations were eliminated • Reduced the weight of each part by 30% • Collaborated with the customer to participate in the SPE Automotive Innovation Awards Therma-Tech™ TT6600-5001 EC Grey KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/resources/ISO14001.2015PolyOneShanghai%25282018-2021%2529.pdf
RTF Template P lace and date: For the is suing office: Shanghai, 30 March, 2018 DNV GL – Business Assurance Suite A, Building 9, No.1591 Hongqiao Road, Changning District, Shanghai 200336, P.R.
https://www.avient.com/sites/default/files/2023-08/Avient General Purchase Conditions.pdf
Each policy shall provide for thirty (30) days’ prior written notice to be given by insurer to Avient in the event of any termination, non-renewal or cancellation, or any material change in coverage or deductibles.
https://www.avient.com/sites/default/files/2021-10/microbial-susceptibility-of-various-polymers-and-evaluation.pdf
Comp. 2006, 8, 30. [11] P.
Sci. 2013, 35, 381. [30] F.
Eng., C 2010, 30, 705. [34] J.